SCHEMBL15280822

SCHEMBL15280822

Cc1cc(C(=O)O[C@@H]2OC3COC(=O)c4cc(O)c(O)c(O)c4-c4c(cc(O)c(O)c4O)C(=O)O[C@H]3[C@H](O)C2O)cc(O)c1O

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 2/20 0.88
PRKD3 O94806 8/20 0.75
PRKCG P05129 8/20 0.75
PRKCB P05771 8/20 0.75
PRKCA P17252 8/20 0.75
PRKCH P24723 8/20 0.75
PRKCI P41743 8/20 0.75
PRKCE Q02156 8/20 0.75
PRKCQ Q04759 8/20 0.75
PRKCZ Q05513 8/20 0.75
PRKCD Q05655 8/20 0.75
PRKD1 Q15139 8/20 0.75
USP2 O75604 1/20 0.75
LMNA P02545 1/20 0.75
POLB P06746 1/20 0.75
GAA P10253 1/20 0.75
MAPT P10636 1/20 0.75
HPGD P15428 1/20 0.75
TNNI3 P19429 1/20 0.75
APEX1 P27695 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Strictinin SCHEMBL17148972 0.93 RAD52 (1.00) RAD52PRKD3PRKCGPRKCBPRKCA
Strictinin SCHEMBL15281508 0.93 RAD52 (1.00) RAD52PRKD3PRKCGPRKCBPRKCA
Strictinin SCHEMBL26093001 0.93 RAD52 (1.00) RAD52PRKD3PRKCGPRKCBPRKCA
Strictinin SCHEMBL29369362 0.93 RAD52 (1.00) RAD52PRKD3PRKCGPRKCBPRKCA
Strictinin SCHEMBL14614086 0.93 RAD52 (1.00) RAD52PRKD3PRKCGPRKCBPRKCA
Strictinin SCHEMBL15262426 0.93 RAD52 (1.00) RAD52PRKD3PRKCGPRKCBPRKCA
SCHEMBL20409294 0.93 PRKD3 (0.88) RAD52PRKD3PRKCGPRKCBPRKCA
SCHEMBL30385544 0.86 BACE1 (0.85) RAD52PRKD3PRKCGPRKCBPRKCA
SCHEMBL21566460 0.86 BACE1 (0.85) RAD52PRKD3PRKCGPRKCBPRKCA
SCHEMBL12824705 0.86 BACE1 (0.85) RAD52PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130252909-A1 TANNIN INHIBITORS OF HIV UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2013-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130252909-A1 TANNIN INHIBITORS OF HIV SERPINB1, TSN, FURIN RAD52 1633/4885PRKD3 2844/4885PRKCG 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.